NTRR Explores Multiple Avenues to Entry Into $1.7 Billion Medical Marijuana Industry


NTRR Explores Multiple Avenues to Entry Into $1.7 Billion Medical Marijuana Industry

SARASOTA, Fla.--(BUSINESS WIRE)-- Following a trip to California last week to meet with leading innovators in California's medical marijuana (MMJ) industry, Neutra Corp.'s (OTCBB: NTRR) executive leadership is pursuing a variety of paths to entry into the booming $1.7 billion U.S. MMJ market.

In addition to exploring new ways to deliver improved production support, logistics and legal services to emerging players in the burgeoning industry, the company is also scouring for new advances in cannabis technologies, including high-efficiency production systems and innovative plant-grooming hardware, primed for marketing and development.

One avenue that NTRR is pursuing includes opportunities to leverage technology developed by Purlife Distributors, Inc., to improve hygienic conditions in the MMJ production and distribution chain. Purlife is the exclusive Canadian distributor of a patent-pending, water-based solution known as PurTeq, which forms an invisible, long-lasting coating that actively protects surfaces from the build-up of bacteria, molds, germs and allergens—all of which can threaten to turn cannabis products into health hazards.

These potentially lucrative opportunities will be pursued by Cannabis Technologies, Inc., the new Los Angeles-based subsidiary founded by NTRR to engineer its market strategy in the MMJ sector. Demand for innovations in the marketplace is high: Demand for high-quality medicinal buds could potentially spur retail medical marijuana sales to an estimated $6 billion by 2018.

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (CBIS), Medical Marijuana Inc. (MJNA), HEMP Inc. (HEMP) and Growlife Inc. (PHOT).

For more information on NTRR's MMJ initiative, please visit www.neutracorp.com/investors.html.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO

KEYWORDS: United States North America Canada California Florida


The article NTRR Explores Multiple Avenues to Entry Into $1.7 Billion Medical Marijuana Industry originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.